Dosch Pharmaceuticals Pvt Ltd, a amalgamated private limited company, was established on 20 April 1992 in Mumbai, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the pharma sector, it holds CIN: U24230MH1992PTC066403. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.86 Cr.
It upholds a compliant status. Employing 10 professional, Its leadership includes Ashay Sanjay Doshi (Director), Sanjay Kanaiyalal Doshi (Managing Director), Prachi Sanjay Doshi (Whole-Time Director). Past directors included Ashay Sanjay Doshi, Sanjay Kanaiyalal Doshi, Prachi Sanjay Doshi. It holds no open charges and ₹177.82 Cr settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 15 C Laxmi Indl Estatenew Link Road Andheri West, Mumbai, Maharashtra, 400053.
U24230MH1992PTC066403
066403
20 April 1992
₹3.00 Cr
₹1.86 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Dosch Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashay Sanjay Doshi | Director | 02 May 2014 | Current |
| Sanjay Kanaiyalal Doshi | Managing Director | 20 Apr 1992 | Current |
| Prachi Sanjay Doshi | Whole-Time Director | 31 Oct 1992 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 22 Feb 2011 | Past |
| Pramod Abcsdd | Managing Director | 22 Feb 2011 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Managing Director | 10 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dosch Pharmaceuticals Pvt Ltd, for the financial year ended 2018, experienced significant growth in revenue, with a 24.5% increase. The company also saw a substantial fall in profitability, with a 5442.74% decrease in profit. The company's net worth dipped by a decrease of 2.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Dosch Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,778,212,661.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2014 | Infina Finance Private Limited | ₹108.00 Cr | Satisfied |
| 17 Oct 2014 | Kotak Mahindra Investments Limited | ₹40.00 Cr | Satisfied |
| 03 Sep 2004 | Citicorp Finance India Limited | ₹0.61 M | Satisfied |
| 23 Mar 2003 | State Bank Of India | ₹4.60 M | Satisfied |
| 10 May 1993 | State Bank Of India | ₹14.65 Cr | Satisfied |
Explore comprehensive loan charge details -
Dosch Pharmaceuticals has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dosch Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dosch Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dosch Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
Dosch Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was recorded as a recent event.
A charge registered on 19 Dec 2014 via Charge ID 10543342 with Infina Finance Private Limited was fully satisfied on 13 Oct 2017. was recorded as a recent event.
A charge registered on 17 Oct 2014 via Charge ID 10543339 with Kotak Mahindra Investments Limited was fully satisfied on 13 Oct 2017. was recorded as a recent event.
A charge registered on 10 May 1993 via Charge ID 80037269 with State Bank Of India was fully satisfied on 13 Oct 2017. was recorded as a recent event.
A charge registered on 04 May 1993 via Charge ID 80037270 with State Bank Of India was fully satisfied on 13 Oct 2017. was recorded as a recent event.
The CIN of Dosch Pharmaceuticals Pvt Ltd is U24230MH1992PTC066403.
Dosch Pharmaceuticals Pvt Ltd is headquartered at 15 C Laxmi Indl Estatenew Link Road Andheri West, Mumbai, Maharashtra, 400053.
Dosch Pharmaceuticals Pvt Ltd was incorporated on 20 April 1992.
The current directors of Dosch Pharmaceuticals Pvt Ltd are
The primary industry of Dosch Pharmaceuticals Pvt Ltd is Pharma.
Dosch Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Dosch Pharmaceuticals Pvt Ltd is ₹3.00 Cr, and the paid-up capital is ₹1.86 Cr.
The compliance status of Dosch Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX